{"title":"腺泡细胞衍生外泌体减轻急性胰腺炎的严重程度。","authors":"Yulin Guo, Feng Cao, Yixuan Ding, Jiongdi Lu, Shuang Liu, Fei Li","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis (AP) is a serious and can be lethal disease, with an incidence of 13 to 45 per 100,000 individuals per year. The underlying mechanism of AP is not fully understood. Exosomes have recently been identified as intercellular messengers that can participate in the pathogenesis of various diseases. Exosomes secreted by noninflammatory acinar cells may affect the activated and injured acinar cells during AP.</p><p><strong>Aim: </strong>To investigate the effect of exosomes derived from acinar cells on the pathogenesis of AP.</p><p><strong>Methods: </strong>Nanoparticle tracking analysis was applied to evaluating the exosomes derived from AR42J acinar cells. The viability and apoptosis of AP in vitro model cells were evaluated. Wistar rats were used to establish the in vivo AP rat model and the levels of serum pro-inflammatory cytokines and morphological changes in the pancreatic tissues were assessed. RNA sequencing and Kyoto Encyclopedia of Genes and Genomes databases (KEGG) based RNA enrichment analyses were applied to exploring the mechanisms underlying the effect of exosomes on the pathogenesis of AP.</p><p><strong>Results: </strong>Acinar cell exosomes reduced the level of intracellular ROS production and improved the viability of AP model acinar cells by inhibiting apoptosis during AP. The exosomes decreased the circulating levels of IL-6 and TNF-alpha, and reduced the pathological scores and wet/dry weight ratios of pancreatic tissue in AP in vivo model rats. Among the upregulated and downregulated RNAs analyzed, the MAPK and NF-kappaB signaling pathways might be involved in the mechanisms underlying the protective effects of acinar cell-derived exosomes in AP.</p><p><strong>Conclusion: </strong>Acinar cell-derived exosomes could reduce the apoptosis and ROS production in acinar cells during AP, and may alleviate the severity of AP via the MAPK and NF-kappaB signaling pathways.</p>","PeriodicalId":11379,"journal":{"name":"Discovery medicine","volume":"31 163","pages":"95-105"},"PeriodicalIF":2.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acinar Cells Derived Exosomes Alleviate the Severity of Acute Pancreatitis.\",\"authors\":\"Yulin Guo, Feng Cao, Yixuan Ding, Jiongdi Lu, Shuang Liu, Fei Li\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Acute pancreatitis (AP) is a serious and can be lethal disease, with an incidence of 13 to 45 per 100,000 individuals per year. The underlying mechanism of AP is not fully understood. Exosomes have recently been identified as intercellular messengers that can participate in the pathogenesis of various diseases. Exosomes secreted by noninflammatory acinar cells may affect the activated and injured acinar cells during AP.</p><p><strong>Aim: </strong>To investigate the effect of exosomes derived from acinar cells on the pathogenesis of AP.</p><p><strong>Methods: </strong>Nanoparticle tracking analysis was applied to evaluating the exosomes derived from AR42J acinar cells. The viability and apoptosis of AP in vitro model cells were evaluated. Wistar rats were used to establish the in vivo AP rat model and the levels of serum pro-inflammatory cytokines and morphological changes in the pancreatic tissues were assessed. RNA sequencing and Kyoto Encyclopedia of Genes and Genomes databases (KEGG) based RNA enrichment analyses were applied to exploring the mechanisms underlying the effect of exosomes on the pathogenesis of AP.</p><p><strong>Results: </strong>Acinar cell exosomes reduced the level of intracellular ROS production and improved the viability of AP model acinar cells by inhibiting apoptosis during AP. The exosomes decreased the circulating levels of IL-6 and TNF-alpha, and reduced the pathological scores and wet/dry weight ratios of pancreatic tissue in AP in vivo model rats. Among the upregulated and downregulated RNAs analyzed, the MAPK and NF-kappaB signaling pathways might be involved in the mechanisms underlying the protective effects of acinar cell-derived exosomes in AP.</p><p><strong>Conclusion: </strong>Acinar cell-derived exosomes could reduce the apoptosis and ROS production in acinar cells during AP, and may alleviate the severity of AP via the MAPK and NF-kappaB signaling pathways.</p>\",\"PeriodicalId\":11379,\"journal\":{\"name\":\"Discovery medicine\",\"volume\":\"31 163\",\"pages\":\"95-105\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Discovery medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discovery medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Acinar Cells Derived Exosomes Alleviate the Severity of Acute Pancreatitis.
Background: Acute pancreatitis (AP) is a serious and can be lethal disease, with an incidence of 13 to 45 per 100,000 individuals per year. The underlying mechanism of AP is not fully understood. Exosomes have recently been identified as intercellular messengers that can participate in the pathogenesis of various diseases. Exosomes secreted by noninflammatory acinar cells may affect the activated and injured acinar cells during AP.
Aim: To investigate the effect of exosomes derived from acinar cells on the pathogenesis of AP.
Methods: Nanoparticle tracking analysis was applied to evaluating the exosomes derived from AR42J acinar cells. The viability and apoptosis of AP in vitro model cells were evaluated. Wistar rats were used to establish the in vivo AP rat model and the levels of serum pro-inflammatory cytokines and morphological changes in the pancreatic tissues were assessed. RNA sequencing and Kyoto Encyclopedia of Genes and Genomes databases (KEGG) based RNA enrichment analyses were applied to exploring the mechanisms underlying the effect of exosomes on the pathogenesis of AP.
Results: Acinar cell exosomes reduced the level of intracellular ROS production and improved the viability of AP model acinar cells by inhibiting apoptosis during AP. The exosomes decreased the circulating levels of IL-6 and TNF-alpha, and reduced the pathological scores and wet/dry weight ratios of pancreatic tissue in AP in vivo model rats. Among the upregulated and downregulated RNAs analyzed, the MAPK and NF-kappaB signaling pathways might be involved in the mechanisms underlying the protective effects of acinar cell-derived exosomes in AP.
Conclusion: Acinar cell-derived exosomes could reduce the apoptosis and ROS production in acinar cells during AP, and may alleviate the severity of AP via the MAPK and NF-kappaB signaling pathways.
期刊介绍:
Discovery Medicine publishes novel, provocative ideas and research findings that challenge conventional notions about disease mechanisms, diagnosis, treatment, or any of the life sciences subjects. It publishes cutting-edge, reliable, and authoritative information in all branches of life sciences but primarily in the following areas: Novel therapies and diagnostics (approved or experimental); innovative ideas, research technologies, and translational research that will give rise to the next generation of new drugs and therapies; breakthrough understanding of mechanism of disease, biology, and physiology; and commercialization of biomedical discoveries pertaining to the development of new drugs, therapies, medical devices, and research technology.